Menu

Sex Differences in TBI

Researchers are finding that male and female mice may respond to traumatic brain injuries differently.

Oct 20, 2015
Bob Grant

WIKIMEDIA, RAMAScientists delving into the neurological underpinnings of traumatic brain injuries (TBI) are finding that there may be crucial differences in the long-term effects of the events that depend not only on the insult, but also on the victim. “No two brain injuries are identical,” University of Pennsylvania neuroscientist Akiva Cohen said during a press conference held at the Society for Neuroscience (SfN) annual meeting in Chicago on Monday (October 19). “Brain injury, like many pathologies these days, constitutes a spectrum.”

In addition to a severity spectrum that spans mild to severe, brain injuries may differ in terms of how male and female animals respond to them, according to Ramesh Raghupathi, a neurobiologist at Drexel University. Raghupathi and his colleagues have found that young male mice suffer more depressive behaviors than female mice at both four and eight weeks after mild TBI, and females display more headache-like symptoms after similar insults, which can include concussion. “All of these animals at these times after injury are cognitively normal,” Raghupathi told reporters. “And they do not have any movement problems.” Raghupathi and his colleagues also found molecular differences that may underlie the sex differences in TBI response that they observed. “In the male mice,” he said, “there is a dramatic difference in dopamine transmission” compared to the uninjured mice.” Researchers have previously linked impaired dopamine signaling to depression.

Raghupathi’s team tested for the lingering effects of TBI in mice by subjecting the animals to certain swimming tests—which are accepted as proxies for depression—and by using a thin filament to touch the faces of the rodents and recording their sensitivity as a measure of headache-like behaviors. Raghupathi said that he and his colleagues will now seek to further explore the molecular differences that may be at play behind the behavioral differences in male and female mice following TBI. “Our future work is developing these models and looking at the effect of dopaminergic signaling as the underlying basis of these problems,” he said.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.